Holger Weis - 22 Jun 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Filing time
24 Jun 2022, 16:30:48 UTC
Previous filing
03 Sep 2021
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +40,000 +33% $0 160,167 22 Jun 2022 Direct F1
holding TCRT Common Stock 19,000 22 Jun 2022 By spouse
holding TCRT Common Stock 1,000 22 Jun 2022 By child
holding TCRT Common Stock 1,240 22 Jun 2022 By child
holding TCRT Common Stock 200 22 Jun 2022 By child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +100,000 $0 100,000 22 Jun 2022 Common Stock 100,000 $0.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,000 shares held in a joint account by the Reporting Person and his spouse.
F2 The option vests in twelve equal monthly installments beginning on July 13, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney